Concepedia

Henry H. Hsu

HH

34

Publications

4.4K

Citations

21

H-Index

1991

Active since

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Stanford University

Cornell University

Plexxikon (United States)

Henry H. Hsu is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, immunology, and oncology.

ORCID

Top concepts

Publications per year

1991–2024

34

Publications

34

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

Vallerie V. McLaughlin, Ronald J. Oudiz, Adaani Frost et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 620 citations

Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor

William D. Tap, Zev A. Wainberg, Stephen P. Anthony et al. · New England Journal of Medicine · 2015 · 571 citations

Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study

Nicholas Butowski, Howard Colman, John de Groot et al. · Neuro-Oncology · 2015 · 562 citations · Full text

Recurrent and acquired hepatitis C viral infection in liver transplant recipients

Teresa L. Wright, Elizabeth Donegan, Henry H. Hsu et al. · Gastroenterology · 1992 · 506 citations · Full text

Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial

William D. Tap, Hans Gelderblom, Emanuela Palmerini et al. · The Lancet · 2019 · 454 citations · Full text

, , +9

Rows per page

1–5 of 34